Study of Avelumab and/or Radiation Therapy in People With Advanced Merkel Cell Carcinoma
Condition: Merkel Cell Carcinoma
Interventions: Drug: Avelumab; Radiation: Comprehensive Ablative Radiation Therapy
Sponsors: Memorial Sloan Kettering Cancer Center; EMD Serono
Source: View full study details on ClinicalTrials.gov
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
March 11, 2021 /
/ in Oncology